Jürgen Rech
- Rheumatology top 0.1%
- Rheumatoid Arthritis Research and Therapies 72
- Spondyloarthritis Studies and Treatments 54
- Systemic Lupus Erythematosus Research 32
- Immunology top 0.5%
- Psoriasis: Treatment and Pathogenesis 30
- Hematology top 0.5%
- Autoimmune and Inflammatory Disorders Research 40
- Genetics top 1%
- Nephrology top 1%
-
- Vasculitis and related conditions 23
-
- Bone and Joint Diseases 21
-
- Inflammasome and immune disorders 15
- Co-authors
- Georg SchettMatthias EnglbrechtAxel J. HueberStephanie FinzelArnd KleyerBernhard MangerKlaus EngelkeDavid Simón
- Cited by
- RheumatologyImmunologyHematology
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Jürgen Rech
173 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Rheumatology 3.7k
- Immunology 2.5k
- Hematology 1.2k
- Genetics 768
- Nephrology 504
Countries citing papers authored by Jürgen Rech
This map shows the geographic impact of Jürgen Rech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Rech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Rech more than expected).
Fields of papers citing papers by Jürgen Rech
This network shows the impact of papers produced by Jürgen Rech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Rech. The network helps show where Jürgen Rech may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jürgen Rech, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 8 | |
| 9 | 2020 | 9 | |
| 10 | 2020 | 45 | |
| 11 | 2020 | 10 | |
| 12 | 2019 | 16 | |
| 13 | 2019 | 100 | |
| 14 | SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: LONG-TERM (4-YEAR) DATA FROM A PHASE 3 STUDY | 2018 | 1 |
| 15 | 2017 | 1 | |
| 16 | 2017 | 21 | |
| 17 | Trial of Tocilizumab in Giant-Cell Arteritisbreakdown → | 2017 | 815 |
| 18 | Hochauflösende periphere quantitative CT (HR-pQCT): Neue Einblicke in die Arthritis | 2013 | 3 |
| 19 | First in Patient Study of Anti-GM-CSF Monoclonal Antibody (MOR103) in Active Rheumatoid Arthritis: Results of a Phase 1b/2a Randomized, Double-Blind, Placebo-Controlled Trial | 2012 | 9 |
| 20 | Stimulatory Autoantibodies against β2-adrenergic Receptors in Open-angle Glaucoma - Effect of Immunoadsorption on Antibody Level and Intraocular Pressure | 2011 | 1 |
About Jürgen Rech
Jürgen Rech is a scholar working on Rheumatology, Hematology and Immunology, having authored 187 papers that have together received 7.0k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (72 papers), Spondyloarthritis Studies and Treatments (54 papers), Autoimmune and Inflammatory Disorders Research (40 papers), Systemic Lupus Erythematosus Research (32 papers), Psoriasis: Treatment and Pathogenesis (30 papers), Vasculitis and related conditions (23 papers), Bone and Joint Diseases (21 papers) and Inflammasome and immune disorders (15 papers). The work is most often cited by research in Rheumatology (3.7k citations), Immunology (2.5k citations) and Hematology (1.2k citations). Jürgen Rech has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Georg Schett, Matthias Englbrecht, Axel J. Hueber, Stephanie Finzel, Arnd Kleyer, Bernhard Manger, Klaus Engelke, David Simón, Hendrik Schulze‐Koops and Daniël Blockmans. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.